Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes
Clinical trial NCT00568074 · COMPLETED
Trial details
- NCT number
- NCT00568074
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-16
- Primary completion
- 2004-09-02
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.